Running head: EVALUATION OF RHEUMATOID ARTHRITIS
Evaluation of Rheumatoid Arthritis
Lurissa Osmialowski
Chamberlain College of Nursing
NR503: Population Health Epidemiology and Statistical Principles
July 2019
EVAL
...
Running head: EVALUATION OF RHEUMATOID ARTHRITIS
Evaluation of Rheumatoid Arthritis
Lurissa Osmialowski
Chamberlain College of Nursing
NR503: Population Health Epidemiology and Statistical Principles
July 2019
EVALUATION OF RHEUMATOID ARTHRITIS
Evaluation of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic disease that is characterized by
inflammation of the synovial membrane in the joints (Aletaha, & Smolen, 2018). It is
common disease worldwide and continues to progressively provide optimal outcomes as
a better understanding of the disease process is being discovered. The purpose of this
paper is to discuss the significance of RA, current surveillance methods, descriptive
epidemiology analysis, screening and diagnosis, and a plan of action to address the
prevalence of RA.
Background and Significance of RA
The Mayo Clinic (2019) defines arthritis as the inflammation and tenderness
involving one or more than one of the joints in the body. Rheumatoid Arthritis (RA)
specifically affects the synovial membrane of the joint causing inflammation and
discomfort due the destruction of the articular cartilage and articular bone (Aletaha &
Smolen, 2018). RA is caused by an autoimmune response where the body’s immune
system is known to attack its own healthy cells (CDC, 2019). RA commonly affects the
joints in the hands, wrists, and knees, but is not limited to these areas. The signs and
symptoms of RA include flare-ups and remission periods. During a flare, a person might
experience rheumatoid nodules, pain or achiness of the joints, stiffness in the joints,
tenderness and swelling in one or more joints, weight loss, fever, tiredness, or weakness
throughout the body, as well as cardiovascular disease (CDC, 2019).
There are an estimated number of about 54.4 million adults, equal to or over the
age of 18, which have been diagnosed with arthritis in the United States (Guglielmo et al.
2019). The most recent Morbidity and Mortality Weekly Report written in May of 2019
2
EVALUATION OF RHEUMATOID ARTHRITIS
discussed the state prevalence of arthritis for the year 2017. The median state prevalence
for the U.S. in 2017 of adults with arthritis was 22.8% (Gugleilmo et al., 2019). The
highest prevalence of arthritis presented in the Appalachian region and the lowest
prevalence presented in the Mississippi Valley regions. The Appalachian region included
all of West Virginia, and parts of Alabama, Georgia, Kentucky, Maryland, New York,
North Carolina, Ohio, Pennsylvania, South Carolina, and Virginia. Age-standardized
prevalence increased with age, ranging from 8.1% for those aged 18-44, to 50.4% for
those aged greater than or equal to 65 y
[Show More]